<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
FORM 15
Certification and Notice of Termination
of Registration under Section 12 (g) of
the Securities Exchange Act of 1934 or
Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities
Exchange Act of 1934.
-----------
COMMISSION FILE NUMBER 1-12968
LXR Biotechnology, Inc.
(Exact name of registrant as specified in its charter)
3095 Richmond Parkway, Suite 213
Richmond, California 94806
(510) 758-4396
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
COMMON STOCK, $0.0001 PAR VALUE PER SHARE
(Title of each class of securities covered by this Form)
NONE
(Titles of all other classes of
securities for which a duty to
file reports under section 13
(a) or 15 (d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) { X } Rule 12h-3(b)(1)(ii) { }
Rule 12g-4(a)(1)(ii) { } Rule 12h-3(b)(2)(I) { }
Rule 12g-4(a)(2)(i) { } Rule 12h-3(b)(2)(ii) { }
Rule 12g-4(a)(2)(ii) { } Rule 15d-6 { }
Rule 12h-3(b)(1)(i) { X }
Approximate number of holders of record as of the certification or notice date:
276
<PAGE> 2
Pursuant to the requirements of the Securities Exchange Act of 1934, LXR
Biotechnology, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
DATE: December 28, 1999
LXR Biotechnology, Inc.
By: /s/ Paul J. Hastings
------------------------------------
Title: Director
---------------------------------
